Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study

Hydroxychloroquine has been touted as a potential COVID-19 treatment. Tocilizumab, an inhibitor of IL-6, has also been proposed as a treatment of critically ill patients. In this retrospective observational cohort study drawn from electronic health records we sought to describe the association betwe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Ip, Andrew, Berry, Donald A., Hansen, Eric, Goy, Andre H., Pecora, Andrew L., Sinclaire, Brittany A., Bednarz, Urszula, Marafelias, Michael, Berry, Scott M., Berry, Nicholas S., Mathura, Shivam, Sawczuk, Ihor S., Biran, Noa, Go, Ronaldo C., Sperber, Steven, Piwoz, Julia A., Balani, Bindu, Cicogna, Cristina, Sebti, Rani, Zuckerman, Jerry, Rose, Keith M., Tank, Lisa, Jacobs, Laurie G., Korcak, Jason, Timmapuri, Sarah L., Underwood, Joseph P., Sugalski, Gregory, Barsky, Carol, Varga, Daniel W., Asif, Arif, Landolfi, Joseph C., Goldberg, Stuart L.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7425928/
https://ncbi.nlm.nih.gov/pubmed/32790733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0237693
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados